Rubinstein, G.* ; Fedtke, V.* ; Then, C.* ; Nowak, E.* ; Vogel, F.* ; Braun, L.* ; Zopp, S.* ; Zimmermann, P.* ; Peters, A. ; Heier, M. ; Linkohr, B. ; Roden, M.* ; Bidlingmaier, M.* ; Beuschlein, F.* ; Reincke, M.* ; Ritzel, K.*
Long-term metabolic consequences: Persistence of visceral obesity and diabetes mellitus after remission from Cushing's syndrome.
Diabetes Res. Clin. Pract. 239:113436 (2026)
Aims: Cushing's syndrome (CS) is associated with increased cardiovascular morbidity and mortality, both of which may persist after long-term remission. Our aim was to evaluate the prevalence of type 2 diabetes mellitus, fat distribution and other metabolic characteristics in patients with prior CS compared with matched population-based controls to assess metabolic risk factors. Methods: Comorbidities were retrospectively analyzed in a cohort of 99 patients with CS from a single tertiary care center. Patients were longitudinally evaluated at baseline during active disease and at 7 years after biochemical remission. Data were compared to a control group matched for age and sex (n = 396) from the KORA study in a 1:4 fashion. Results: Despite long-term improvements, patients with CS in sustained remission still exhibit adverse metabolic outcomes 7 years after remission, including higher relative fat mass (39% vs. 35%, p = 0.0013), a higher waist-to-hip ratio (0.89 vs. 0.82, p < 0.0001), elevated HbA1c (5.5% vs. 5.4%, p = 0.0087), and increased diabetes prevalence (19% vs. 4%, p < 0.0001) compared with controls. These persistent metabolic alterations were strongly associated with inflammatory markers, suggesting inflammation as a potential contributor to the sustained diabetes risk. Conclusion: Patients with prior CS remain burdened by adverse metabolic profiles that may contribute to their increased long-term cardiovascular risk.
Altmetric
Weitere Metriken?
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Co-morbidities ; Cushing'sdisease ; Cushing'ssyndrome ; Diabetesmellitus ; Remission; Cardiovascular Risk; Active Disease; Mortality; Outcomes
Keywords plus
ISSN (print) / ISBN
0168-8227
e-ISSN
1872-8227
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 239,
Heft: ,
Seiten: ,
Artikelnummer: 113436
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
Förderungen
State of Bavaria
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Munich Clinician Scientist Program I (MCSP) of the LMU Muenchen
Clinician Scientist Program RISE (Rare Important Syndromes in Endocrinology)
German Research Foundation (DFG)
European Community
Schmutzler-Stiftung
Ministry of Culture and Science of the State of North Rhine-Westphalia
German Federal Ministry of Health (BMG) to the German Diabetes Center
Federal Ministry for Research (BMBF) to the German Center for Diabetes Research
Helmholtz Zen-trum Muenchen German Research Center for Environmental Health by German Federal Ministry of Education and Research (BMBF)
Else Kroener-Fresenius Stiftung
Copyright